TheraPharm
Dec 01, 2020
BASE10 Collaboration; Advaxis Public offerings; Takeda’s CABOMETYX Japan approval; TheraPharm Acquisition
BASE10 Collaborates with DNA Link for COVID-19 Antibody Test Research US-based BASE10 Genetics and Korean firm DNA Link announced a collaboration on a research project to appraise the usability of the DNA Link's antibody test, AccuFind COVID-19 IgG, in a healthcare setting. Currently, most antibody tests avai...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
